|
|
|
Insider
Information: |
Ivers-Read Gillian C |
Relationship: |
See Remarks |
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
293,612 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,404 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
293,612 |
|
|
Total
Value |
$4,404 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
27
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
24
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,222.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
EVP, Development Opera... |
2008-03-07 |
0 |
2004-12-09 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
293,612 |
2011-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-12-10 |
4 |
OE |
$3.28 |
$226,205 |
D/D |
68,965 |
284,487 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-12-10 |
4 |
D |
$4.81 |
$252,270 |
D/D |
(52,447) |
232,040 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2008-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(46,040) |
0 |
0 |
- |
|
WTKND |
Welltek Incorporated |
Executive Vice President |
|
2005-12-16 |
5 |
OE |
$1.60 |
$69,426 |
D/D |
34,016 |
34,016 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2007-11-08 |
4 |
OE |
$1.60 |
$352,962 |
D/D |
32,813 |
42,989 |
0 |
- |
|
WTKND |
Welltek Incorporated |
Vice President |
|
2004-12-09 |
4 |
S |
$45.50 |
$1,422,545 |
D/D |
(31,250) |
0 |
|
- |
|
WTKND |
Welltek Incorporated |
Vice President |
|
2004-12-09 |
4 |
OE |
$2.40 |
$75,000 |
D/D |
31,250 |
31,250 |
|
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2007-08-24 |
4 |
S |
$38.50 |
$918,292 |
D/D |
(23,840) |
10,176 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,250 |
253,377 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,938 |
284,558 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,997 |
210,271 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2011-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,110 |
213,260 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-02-02 |
4 |
S |
$7.97 |
$87,590 |
D/D |
(10,990) |
244,346 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-03-02 |
4 |
S |
$1.87 |
$20,097 |
D/D |
(10,770) |
274,142 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,375 |
266,427 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
251,684 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
256,630 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
261,699 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
280,845 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
288,190 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
295,618 |
0 |
- |
|
WTKND |
Welltek Incorporated |
Vice President |
|
2004-12-14 |
4 |
OE |
$1.60 |
$12,240 |
D/D |
7,650 |
7,650 |
|
- |
|
WTKND |
Welltek Incorporated |
officerTitle |
|
2005-12-13 |
4 |
S |
$18.37 |
$140,787 |
D/D |
(7,650) |
0 |
|
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
190,083 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-02-04 |
4 |
S |
$8.41 |
$60,586 |
D/D |
(7,204) |
203,067 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|